Atezolizumab Plus Chemotherapy for First-Line Treatment of Nonsquamous NSCLC: Results From the Randomized Phase 3 IMpower132 Trial

Nishio, M; Barlesi, F; West, H; Ball, S; Bordoni, R; Cobo, M; Longeras, PD; Goldschmidt, J; Novello, S; Orlandi, F; Sanborn, RE; Szalai, Z; Ursol, G; Mendus, D; Wang, LJ; Wen, XH; McCleland, M; Hoang, T; Phan, S; Socinski, MA – 2021